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Abstract
Stress is a major risk factor for depression and anxiety. One of the effects of stress is the
(over-) activation of the hypothalamic-pituitary-adrenal (HPA) axis and the release of stress
hormones such as glucocorticoids (GCs). Chronically increased stress hormone levels have
been shown to have detrimental effects on neuronal networks by inhibiting neurotrophic pro-
cesses particularly in the hippocampus proper. Centrally, GCs modulate metabolic as well
as behavioural processes by activating two classes of corticoid receptors, high-affinity
mineralocorticoid receptors (MR) and low-affinity glucocorticoid receptors (GR). Upon acti-
vation, GR can modulate gene transcription either as a monomeric protein, or as a dimer
interacting directly with DNA. GR can also modulate cellular processes via non-genomic
mechanisms, for example via a GPCR-protein interaction. We evaluated the behavioral phe-
notype in mice with a targeted mutation in the GR in a FVB/NJ background. In GRdim/dim
mice, GR proteins form poor homodimers, while the GR monomer remains intact. We evalu-
ated the effect of poor GR dimerization on hippocampus-dependent cognition as well as on
exploration and emotional behavior under baseline and chronically increased stress hor-
mone levels. We found that GRdim/dim mice did not behave differently from GRwt/wt litter-
mates under baseline conditions. However, after chronic elevation of stress hormone levels,
GRdim/dim mice displayed a significant impairment in hippocampus-dependent memory com-
pared to GRwt/wt mice, which correlated with differential expression of hippocampal Bdnf/
TrkB and Fkbp5.
Introduction
Stress is commonly defined as a state of real or perceived threat to homeostasis [1]. Short-term
stress serves as an important mechanism to survive, while chronic stress is detrimental and an
important contributor to major psychiatric disorders such as depression and anxiety [2]. In
the presence of stressors, the hypothalamic-pituitary-adrenal (HPA) axis is activated and initi-
ates a complex range of responses involving the endocrine, nervous and immune system,
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collectively known as the stress response [3, 4]. Centrally, chronic elevation of the stress
response will affect neuronal functioning by inhibiting neurogenesis, proper synaptic pruning
and changes in neurotransmitter systems [5, 6], and induce a wide range of behavioral changes
including cognitive processes.
One of the hormones released in response to stress, are glucocorticoids (GCs). The physio-
logical functions of GCs include regulation of metabolic homeostasis, immune function, cell
proliferation and survival, and behaviour including cognition [7–9], while endogenous excess
or dysregulation of GCs is associated with mood changes, including depression and hypo-
manic symptomatology [10].
GCs exert their effects via two receptors: the mineralocorticoid receptor (MR) and the glu-
cocorticoid receptor (GR), which differ in their affinity and regional distribution in the brain.
The MR has a more restricted distribution with high expression in the hippocampus and lower
levels in cortical layers and the amygdala [11]. GR is expressed much more widely and is found
in high concentrations in the hippocampus, aminergic neurons in the brainstem and in nuclei
that are part of the HPA-axis, such as the hypothalamic PVN [12, 13]. Due to their difference
in affinity for GCs, MRs are substantially activated by low levels of GCs, such as those circulat-
ing at rest, whereas lower-affinity GR becomes fully occupied only when there are high levels
of hormone, such as during stress exposure and at a circadian peak and by pharmacological
treatment with GCs [12]. GRs exert their action either as monomers or as homodimers by
directly influencing DNA transcription. In addition, GCs can exert fast non-genomic effects,
for example by interacting with membrane-bound GR proteins [14–16].
Patients suffering from major depression disorder (MDD) have been linked to dysfunction
in the HPA axis [17], reduced sensitivity and deregulated feed-back mechanisms to GC [18].
While mutations within the ligand binding domain of GR gene can lead to a complex endo-
crinological phenotype, typified as ‘GC resistance syndrome’ [19], polymorphic variations
might account for more subtle changes in GR function and indeed have been associated with
MDD [20]. Cognitive aspects of depression mostly aggregate around two main foci: cognitive
biases (‘negative thinking’) and cognitive deficits, such as impaired attention and concentra-
tion, short-term memory, autobiographical memory specificity and executive function [21–
23]. The hippocampus has been attributed a major role in the cognitive impairment observed
in MDD, due to its general central role in learning and memory [24–26], and the structural
changes observed in the hippocampus proper in patients with MDD. These changes are direct
or indirect consequences of excessive circulating GC [27–29] affecting neurotrophic processes
and synaptic pruning. Furthermore, improving hippocampal neurogenesis has been proposed
to be a promising therapeutic avenue for MDD [30]. In addition, dysfunction in dopamine sig-
naling and in the salience network have been associated with MDD [31] and more specifically
with impaired specificity of autobiographical memory [32–36]. In mice, inhibition of dopami-
nergic signaling or inactivation of dopaminergic receptors in the hippocampus induced
depression-like behavioral phenotypes and impaired cognition [37–45].
We made use of the GRdim/dim mutant mouse [46] with a point mutation (A458T) in the
DNA binding domain (DBD) of the GR, by which it forms much weaker homodimers and less
robust DNA binding, while leaving the monomeric GR function intact [46, 47]. The GRdim/dim
mouse model has proven important to dissect mechanistic pathways employed by GR in con-
trolling (patho-)physiological phenomena. We compared the cognitive phenotype of GRdim/
dim mutant mice to their wildtype litter mates under baseline and under chronic stress hor-
mone levels.
Under baseline conditions we found no effect of the mutation. By contrast, we identified
impairment in hippocampus-dependent memory in these mice under chronic stress condition
implicating monomer-dependent mechanisms in GR regulation of memory.
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Materials and methods
Animals and reagents
GRdim/dim mice were generated by Reichardt et al. and kept on an FVB/NJ background [46].
The mice were made available by Prof. Jan Tuckermann, Ulm University, Germany, and bred
in our laboratories. Heterozygous GRdim/wt mice were intercrossed to generate GRwt/wt and
GRdim/dim homozygous mutant mice. All offspring was genotyped by PCR on genomic DNA
isolated from toe biopsies. Mice were bred in IRC/VIB Ghent and kept in individually venti-
lated cages under a 12-hour dark/light cycle in a conventional facility. For behavioural testing,
mice were transported to KUL. All mice were 9 weeks old on the first day of testing. We
included n = 12 GRwt/wt and n = 11 GRdim/dim animals in the testing battery. 4 animals died
after baseline testing (n = 3 GRwt/wt and n = 1 GRdim/dim animals) probably due to seizures
[48]. All behavioural testing was performed during the light phase of the activity cycle, with
the exception of the 23h-activity test. We used females only, since stress has clear sex-specific
effects and males have been shown to be more resistant to stress [49, 50]. In addition, female
animals were included due to the propensity of additional stress due to hierarchical fighting in
co-housing male mice. All animal experiments were approved by the animal ethical committee
of University of Leuven.
Reagents
Corticosterone (CORT) (27840, Sigma-Aldrich NV) was dissolved in b-cyclodextrin solution
(4% in tap water, C4767, Sigma-Aldrich NV) to a concentration of 36.5 mg/L [51] and pro-
vided in drinking water over 4 weeks. This dose has been shown to induce depression and anx-
iety-like features in different mouse strains including blunting of corticosterone response
following an acute stressor [51, 52], while increasing the corticosterone levels less than what is
observed after acute or chronic stress exposure [53–55]. Treatment was maintained during
behavioural testing to prevent rebound effects. At the end of the behavioural tests, dorsal hip-
pocampus was isolated and snap frozen.
Timeline of behavioural testing and corticosterone treatment
After one week of habituation (week 1), we first tested all animals under baseline conditions
(week 2–6), and then subjected them to chronic corticosterone treatment for 4 weeks (week
7–10) and testing (week 11–15)(see Fig 1). This schedule allowed for comparison of behaviour
under two conditions within one animal and provided insight into corticosterone effects. In
between the two blocks of behavioural testing, we provided a testing interval of 4 weeks during
which the CORT was administered. Minimal handling was done to the animal. The order of
tests was as follows: open field (OF), elevated plus maze (EPM), 23h cage activity (CA), anhe-
donia (AnH), social preference and social novelty (SPSN), Y-maze spontaneous alternations
(Ym), conditioned place preference (CPP), passive avoidance (PA). EPM testing during CORT
treatment was impossible, because the mice continuously jumped off the setup.
Explorative and emotional behaviour
Spontaneous cage activity (CA) was recorded over a period of 20 hours in a home cage [56].
This test provides insight into general exploration, changes in diurnal pattern or nocturnal
activity, motor impairment, and general arousal. To measure CA, mice were placed individu-
ally in transparent cages (26.7 cm x 20.7 cm) located between three IR photo beams connected
to a computerized activity logger. Activity was registered as the number of beam crossings for
each 30 min interval, during a 20 h recording period. Following a 15 min habituation,
Glucocorticoids and memory loss
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registration of beam crossings started at 4:30 pm during the pre-UCMS activity test and at 4:30
pm during the post-UCMS activity test, with lights being switched off at 7 pm (12h on/off
cycle). Cage activity during the dark phase of the recording period was analysed.
In the open field (OF), we measured locomotor activity, exploratory and emotional behav-
iour as previously described [56]. After a 30-minute dark-adaption period, mice were placed
in the brightly lit open field area (50 x 50cm2). After 1 min of habituation, exploratory behav-
iour was recorded for 10 min using an automated video tracking system (ANY-maze™ Video
Tracking, Stoelting Co. IL, USA). Variables analysed were distance travelled and time spent in
the centre or corner of the open field arena. Centre exploration is usually considered to reflect
conflict resolution, while continuing wall-hugging (thigmotaxis) is a behaviour observed in
conditions that evoke anxious behaviour.
In the elevated plus maze (EPM), we assessed anxiety-related exploration [56]. In contrast
to the open field, the elevated plus maze provides closed arms, which are the preferred zone for
mice. Venturing onto the open and elevated arms is challenging for mice and anxious animals
will avoid the open space entirely. Mice were placed in the centre of a plus-shaped maze, con-
sisting of two open arms (5 cm wide) without walls and two arms closed by side walls. Anxi-
ety-related exploration was recorded for 11 min (1 min habituation and 10 min recording) by
five IR photo beams connected to a computerized activity logger. There is one IR photo beam
at the entry of each arm. One IR beam records the relative time spent in the open arm.
Social behaviour and cognition
Social approach and social memory (SPSN) was assessed in a 3-compartment setup described
previously [57]. In short, the setup consisted of a central start box that connected via a manual
guillotine door to 2-side boxes containing small cylindrical holding cages. The holding cages
could contain one stranger mouse. Exploration was recorded using an overhead webcam and
an automated video tracking system (ANY-maze™ Video Tracking, Stoelting Co. IL, USA).
The test entailed 3 phases. During acclimation, mice were placed in the central chamber for 5
min to habituate to the setup. During this habituation phase, access to the side chambers was
prevented by closing the guillotine doors. After 5 min, a stranger mouse was introduced in one
of the cylindrical cages on either left or right side (side was counter balanced). Approach
behaviour towards the stranger 1 mouse (distance of nose < 2 cm) and preference towards this
mouse over the empty wire cage was recorded for 10 min as a measure of sociability. After 10
min, a second stranger mouse (from a different cage, but same sex), was introduced on the
side of the empty wire cage. Again, approach behaviour was measured for 10 min, and prefer-
ence for stranger 2 over stranger 1 was considered a readout for social novelty and social mem-
ory. Parameters such as path length, walking speed and time spent close to the wire cages were
extracted from ANYmaze tracking software.
Spontaneous alternations in the Y-maze was assessed as a readout of working memory func-
tion [58] as well as responsiveness to novelty [58, 59]. The Y-maze consisted of 3 arms (5cm
Fig 1. Order of tests. Open field (OP), elevated plus maze (EPM), 23h cage activity (CA), anhedonia (AnH), social preference and social novelty (SPSN), Y-maze
spontaneous alternations (Ym), conditioned place preference (CPP), passive avoidance (PA).
https://doi.org/10.1371/journal.pone.0226753.g001
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wide, 30cm long and enclosed by 30 cm high wall made of grey plastic) connected by a central
small area (diameter 5 cm). Mice were placed in the centre for 10 min exploration of all arms.
Locomotion was recorded by a webcam connected to a PC. Entries into all arms were noted
(all 4 paws had to be inside the arm for a valid entry) and an alternation was counted if an ani-
mal entered three different arms consecutively (i.e. 1-2-3, 2-3-1, 3-2-1). Percentage spontane-
ous alternation (%) was calculated according to following formula: [(number of alternations)/
(total number of arm entries-2)]x100 [60, 61].
Novel object recognition was used to evaluate the innate responsiveness to novel objects.
Mice were placed individually in the open field setup for 10 min. After 10 min, 2 identical
objects were placed inside the box and time to explore (approach nose distance < 2cm from
object) was recorded. 24h later, the animals were placed back in the open field, two new objects
(one looking identical and one novel) were placed back in the box, and approach time and
preference for novel object was recorded.
Conditioned place preference assesses the ability of an animal to distinguish and remem-
ber a specific context that was associated with a reward [62, 63]. Based on lesion studies, sev-
eral brain regions such as amygdala, fornix, prefrontal cortex, and hippocampus affect
conditioned place preference [63–65]. The place preference box was a three-compartment
box, 2 large compartments of 30 x 30cm and a small (10 x 10cm) start compartment in
between. The large compartments differed in their contextual configurations (tactile and
olfactory dimensions). One context was consistently associated with a reward, while the
other context was not. After habituation the animals to the reward pellets (in a neutral con-
text) and to the setup (2 x 10min /day), mice were food conditioned to one of the contexts.
During conditioning trials (10 min twice a day) mice are placed in the central start box and
time to retrieve the pellet (latency to reward) and number of errors (entering wrong con-
text) are recorded. After 6 trials, mice are again placed in the start box and time spent in
each context was recorded in the absence of a food reward. Preference for food paired con-
text reflects robust contextual memory.
To assess hippocampus-dependent contextual fear memory retention, animals were tested
in the passive avoidance test [66–70]. Dark-adapted mice were placed in a brightly lit chamber
with access to a dark box. Upon entering the dark box, the access is closed with a door and a
mild foot shock (2 s, 0.3mA) was delivered to establish contextual fear memory. Twenty-four
hours later retention memory was tested by placing the animal again in the lit box and latency
to enter the dark compartment was timed, with 300 s as a cut-off.
qPCR analysis
For the comparison of gene expression, we extracted brains from the CORT animals after test-
ing and included age matched naive animals as baseline condition. After behavioural testing,
RNA was isolated from the dorsal hippocampus with the Aurum kit (Biorad) according to the
manufacturer’s instructions. RNA concentration was measured with the Nanodrop 1000
[ThermoFisher Scientific) and 300–1000 ng RNA was used to prepare cDNA with Superscript
II (Invitrogen). qPCR was performed using the Roche LightCycler 480 system (Applied Biosys-
tems). The best-performing housekeeping genes were determined by Genorm [71]. Results are
given as relative expression (scaled to average) values normalized to the geometric mean of the
housekeeping genes. Primers used for qPCR are depicted in Table 1. We selected the target
genes based on their relevance for GC stimulation: neurogenesis and synaptic function (Bdnf,
TrkB, Fmr1), sensitivity of cells to GC stimulation (Fkbp5), and dopaminergic modulation of
cognitive processes in the hippocampus (D1R, D5R).
Glucocorticoids and memory loss
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Statistical analysis
Sample size calculation: Using preliminary data on CORT treatment of C57BL/6 animals, we
obtained a standard deviation of SD = 4464 (23h CA) and an effect size of d = 1.72. Assuming
a type 1 error of 5% (α = 0.05) and the power of 80%, we calculated a sample size of n = 7/
group. We used 2-way ANOVA, and for post-hoc contrast comparisons Sidak or Tukey cor-
rections for multiple testing (GraphPad Prism1 7 for Windows). For SPSN, we performed
3-way ANOVA (Fisher’s least significant difference post hoc analysis) in Genstat. Animal
numbers differed between baseline and CORT treatment, due to loss of animals as a conse-
quence of higher fatal audiogenic seizure susceptibility of the FVB strain [48]. Data are
expressed as means ±SEMs.
Results
Explorative and emotional behaviour
Cage activity. Under baseline conditions, we observed a typical activity pattern (low activity
during the light phase and high activity during the night) and no differences between GRwt/wt
and GRdim/dim mice [F(1,21) = 1.885, p = 0.1843], as visualized in the overnight activity pattern
(30 min time bins, Fig 2A and 2B, black symbols) as well as the total counts (Fig 2C). Under
chronic corticosterone schedule, most GRwt/wt animals (7 of 9) showed no effect of corticoste-
rone, however, 2 GRwt/wt animals displayed an extreme increase in activity (> 100 000 counts in
23h, Fig 1C). While in GRdim/dim activity was increased in 5 out of 10 animals (Fig 2B and 2C).
Table 1. Primer sequences qPCR.








Fig 2. Overnight cage activity in GRwt/wt and GRdim/dim mice at baseline (BSL) and under chronic corticosterone (CORT) treatment. (A) In GRwt/wt animals cage
activity showed a typical activity pattern over 20h recording at baseline (black symbols, n = 12) or under chronic corticosterone (white symbols, n = 7). (B) GRdim/dim
animals show a similar activity pattern under baseline condition (black symbols, n = 11). Chronic corticosterone treatment (white symbols, n = 10) increased activity
during the night period, but the contrast was not significant. Data are presented as means ±SEMs. (C) Total activity counts show the extreme increase in cage activity in
2 GRwt/wt animals. Each data point reflects one animal, and bars indicate level of median. Baseline: n = 12 GRwt/wt and n = 11 GRdim/dim mice; CORT: n = 7 GRwt/wt and
n = 10 GRdim/dim mice.
https://doi.org/10.1371/journal.pone.0226753.g002
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Two-way ANOVA (excluding the 2 extreme GRwt/wt animals) indicated no genotype [F(1,34) =
1.909, p = 0.176) and no treatment effect [F(1,34) = 2.29, p = 0.139) (Fig 2C).
Open field. Exploration in the open field was assessed by measuring path length (Fig 3A).
In addition, conflict resolution related readouts, such as centre time (Fig 3B), centre visits (Fig
3C) and thigmotaxis (wall hugging or corner time) (Fig 3D) were extracted from video-based
tracking. We observed no genotype effect in path length [F(1,38) = 0.7552, p = 0.39], and only
an effect of treatment [F(1,380 = 5.319, p = 0.026], without interaction. (Fig 3A). Furthermore,
time in centre was similar in both genotypes [F91,38) = 0.053, p = 0.81] and treatment had no
effect [f(1,38) = 3.083, p = 0.087]. Number of visits to the centre were not different between
genotypes [F(1,38) = 0.004, p = 0.949], while factor treatment was [F(1.38) = 6.99, p = 0.0118].
Similarly, no genotype effect was observed for time spent in the corners [F(1,38) = 0.0006,
p = 0.980], nor for treatment [F(1,38) = 3.313, p = 0.766]. However, under corticosterone treat-
ment, we also observed a dramatic change in activity in some animals (in 3 GRwt/wt and in 4
GRdim/dim mice), in particular an increase in body rotations (S1 Fig). Overall, we observed sim-
ilar explorative patterns between the two genotypes at baseline and under CORT treatment.
Elevated plus maze. We performed the elevated plus maze only at baseline, since under
corticosterone, the animals were too active to stay on the setup and made recording impossi-
ble. At baseline, GRdim/dim mice crossed into open arms significantly more often when com-
pared to GRwt/wt mice [t(21) = 2.26, p = 0.0346] (S2 Fig). In conjunction with similar general
activity [total arm entries, t(21) = 0.93, p = 0.3629], this suggests that GRdim/dim are less anxious
than GRwt/wt (S2 Fig).
Social behaviour and cognition
Sociability and Preference of Social Novelty (SPSN). Path lengths (m/min) during each
of the stages were compared using 3-way ANOVA for factor stage (AC, S1, S2), genotype
(GRwt/wt and GRdim/dim) and treatment (baseline or corticosterone) (Fig 4A). We only found
an effect for treatment [F(1, 114) = 37.17, p< 0.001].
During the sociability phase (SP), mice are presented either a stranger mouse (S1) or an
empty (E) cup and time sniffing (distance < 2cm from cup) was scored. Three-way ANOVA
for factor side, genotype and treatment indicated a significant effect for side [F(1,76) = 61,
p< 0.001), and for treatment [F(1,61) = 7.45, p = 0008], but no effect for genotype [F(1,76) =
1.97, p = 0.164]. (Fig 4B). Post hoc comparisons (Fisher’s least significant difference (LSD)
test), indicated both genotypes investigated S1 longer than the empty cage, in baseline condi-
tions and with CORT treatment (GRwt/wt: p< 0.001 in baseline and CORT, GRdim/dim:
p< 0.001 and p< 0.01 in baseline and CORT respectively).
In the last stage, a second stranger is added to the empty wire cage and social memory can
be assessed. Usually, mice will show higher preference to the novel stranger (S2)., Three-way
ANOVA for factor side, genotype and treatment, indicated a significant effect for side [F(1,76)
= 30.25, p< 0.001], but not for genotype [F(1,76) = 1.39, p = 0.243] and treatment [F(1,76) =
0.01, p = 0.908]. There was also a significant interaction between the three factors [F(1,76) =
4.88, p = 0.03]. (Fig 4C). Post hoc analysis with LSD test revealed that, under baseline condi-
tions, GRdim/dim mice showed more interest in S2 (p< 0.01), while GRwt/wt animals did not
(p> 0.05). When treated with CORT, GRwt/wt animals showed an increase interest in S2
(p< 0.001), while GRdim/dim mice did not(p> 0.05), indicating that CORT affected recogni-
tion for the novel stranger (S2).
To account for inter-individual differences in time, we calculated the preference score for
S1 (in SP) and for S2 (in SN) under baseline and under CORT conditions (Fig 4D). Under
baseline conditions, GRdim/dim displayed a significant contrast to chance level (50%) (one
Glucocorticoids and memory loss
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sample t-test to 50%: GRdim/dim SP: [t(10) = 4.52, p = 0.001], SN: [t(10) = 4.98, p = 0.0006]),
while GRwt/wt only in SP [t(11) = 4.166, p = 0.0016], but not during SN [t(11) = 1.06], indicat-
ing reduced social memory under baseline conditions. Under CORT treatment, GRwt/wt dis-
played a significant preference above chance level (SP:[t(8) = 4.599, p = 0.0018]; SN: [t(8) =
4.556, p = 0.0019], while in GRdim/dim the preferences were not different from chance level (SP:
[t(8) = 1.941]; SP: t(8) = 1.109] indicating that in GRdim/dim corticosterone treatment affected
both preference towards S1 and S2.
Spontaneous alternation in Y maz. Working memory was assessed in the Y-maze. 2-way
ANOVA for arm visits indicated an effect for treatment [F(1,38) = 13.04, p = 0.0009], without
an effect for genotype [F(1,38) = 2.895, p = 0.097], indicating that under CORT number of
arm visits were reduced (Fig 5A). When we compared spontaneous alternations (SA), 2-way
ANOVA indicated that there was no effect for factor treatment [F(1,38) = 1.013, p = 0.3216],
but a significant effect for genotype [F(1,380 = 5.467, p = 0.0247] (Fig 5B). Working memory
in the Y-maze is based on the notion that an animal remembers the two arms it visited last and
Fig 3. Explorative behaviour in the open field in GRwt/wt and GRdim/dim mice at baseline (BSL) and under chronic corticosterone (CORT)
treatment. When placed in an open field, overall exploration was similar in both genotypes expressed as path length (A), as time spent in the centre
(B), and number of centre visits (C), and as time spent in the 4 corners (D). Data are expressed as means ± SEMs. Baseline: n = 12 GRwt/wt and n = 11
GRdim/dim mice; CORT: n = 9 GRwt/wt and n = 10 GRdim/dim mice.
https://doi.org/10.1371/journal.pone.0226753.g003
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will choose the most novel arm to enter. This process implies that when the animal arrives at
the decision point where all 3 arms come together, it might briefly pause and then make the
decision which arm to visit. We observed that the SA were similar in GRwt/wt at baseline and
under CORT. However, the significantly reduced number of arm visits could be an indication,
that the decision might be more difficult and might require more time. Indeed the amount of
SA are slightly higher under CORT in GRwt/wt. In contrast, in GRdim/dim mice, number of visits
also decreased under CORT, however, the amount of SA was the same as under baseline con-
ditions. In addition, the SA under CORT was significantly lower than in GRwt/wt mice, which
could point to a reduced hippocampal function in GRdim/dim mice when challenged with
CORT.
Passive avoidance. Contextual fear memory was assessed in a passive avoidance test.
Latency to enter the dark compartment was measured during training (TR) and test (TE)
phase. Under baseline conditions, we observed similar fear memory retention during the test
Fig 4. Sociability (SP) and preference for social novelty (SN) in GRwt/wt (black bars) and GRdim/dim mice (white bars) under baseline and under
chronic corticosterone treatment. Under baseline conditions, no difference in path length (m/min) was observed between the genotypes.CORT
treatment increased path length (m/min) in both genotype similarly in comparison to baseline (A). When presented with a stranger mouse (S1), under
baseline and CORT conditions, both genotypes showed more approach behaviour towards S1 than to an empty (E) cage (B). When presented with a
second stranger (S2), under baseline conditions GRdim/dim mice show a preference towards S2, while under CORT treatment, GRdim/dim mice do not
display preference towards S2 anymore (C). Calculation of individual preference scores indicate that under baseline conditions, both genotypes show
normal social preference (SP: S1-E), however, only GRdim/dim mice show preference for social novelty (SN: S1-S2). Under CORT, GRwt/wt show
preference during SN and SP, while GRdim/dim mice show no preference in SP and SN (D). Data are shown as means ± SEMs. (B-D) � p< 0.05,
��p< 0.01 �� p< 0.01, ���p< 0.001, (one sample t-test to chance level at 50%). Baseline: n = 12 GRwt/wt and n = 11 GRdim/dim mice; CORT: n = 9 GRwt/
wt and n = 10 GRdim/dim mice.
https://doi.org/10.1371/journal.pone.0226753.g004
Glucocorticoids and memory loss
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Fig 5. Spontaneous alternation Y-maze. CORT reduced the number of arm visits compared to baseline in both genotype (A). In contrast, spontaneous alternations
were higher in GRwt/wt mice (B). Data are shown as mean ± SEM. �p< 0.05. Baseline: n = 12 GRwt/wt and n = 11 GRdim/dim mice; CORT: n = 9 GRwt/wt and n = 10
GRdim/dim mice.
https://doi.org/10.1371/journal.pone.0226753.g005
Fig 6. Passive avoidance. During training (TR), the animal received a mild foot shock upon entering the dark
compartment. 24h later during testing (TE), entry to the dark compartment is avoided when contextual memory is
intact. No differences were observed at baseline conditions (BSL). After CORT treatment, the latency in GRdim/dim
mice was significantly lower when compared to BSL, as well as to GRwt/wt mice. Data are presented as mean +/- SEM.
�� p< 0.01 (2-way ANOVA, post hoc with Sidak correction). Baseline: n = 12 GRwt/wt and n = 11 GRdim/dim mice;
CORT: n = 9 GRwt/wt and n = 10 GRdim/dim mice.
https://doi.org/10.1371/journal.pone.0226753.g006
Glucocorticoids and memory loss
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phase. Animals avoided entering the box that had been associated with a mild foot shock (Fig
6). Under CORT schedule, GRwt/wt mice still avoided to enter, while GRdim/dim mice entered
the dark box on average after 100s, indicating that contextual fear memory in GRdim/dim mice
was significantly impaired after chronic corticosterone treatment. Two-way ANOVA indi-
cated a significant effect for phase [F(1,17) = 33.84, p< 0.0001) and a group effect [F(1,17) =
6.084, p = 0.025) with a significant interaction [F(1,17) = 5.8, p = 0.0277). Post-hoc analysis
using Sidak’s correction indicated that under CORT the latency to enter for GRdim/dim was sig-
nificantly different from baseline [q(60) = 4.864, p = 0.0057], as well as from GRwt/wt mice [t
(60) = 4.613, p = 0.0096], and therefore, under chronic corticosterone treatment, GRdim/dim
mice have impaired contextual fear memory retention.
Conditioned place preference (CPP) test. Incentive salience and contextual memory can
be measured by the amount of time the mice spend in the food-paired compartment during a
probe trial. We trained animals for a limited number of trials (6 trials) to associate a food
reward with a certain context. A reduction of time to eat the reward, as well as increase in cor-
rect choices indicated learning. Under baseline conditions, both GRwt/wt and GRdim/dim mice
were able to learn to locate the food reward in the correct context (Fig 6A, 2-way RM ANOVA
day [F(2,28) = 6.305; p = 0.0055, but no effect for genotype [F(1,14) = 0.033)]). While latency
decreased, the number of correct trials displayed a trend to be above chance level (correct tri-
als = 50%) (Fig 7B). During the probe trial, all animals displayed a significant preference to the
correct context that was associated with a reward [F(1,28) = 23.57, p< 0.0001] (Fig 7E), with-
out effect for genotype [F(1,28) = 0, p> 0.99].
Under corticosterone treatment, all animals showed a decrease in latency to collect the food
over days [F(2,34) = 8.69; p = 0.0009], but no genotype effect [F(1,17) = 2.344] (Fig 7C), and
no significant interaction [F(2,34) = 2.948, p = 0.066]. Post-hoc comparison for days, signalled
that GRdim/dim animals improved latency to find the food reward on the third day significantly
over the first day [t(51) = 3.335, p = 0.0048], while in GRwt/wt animals the time to find the food
was similarly low over the 3 days. Number of errors displayed a trend to be above chance level
(Fig 7D). Under corticosterone treatment, 2-way ANOVA indicated a significant effect of con-
text [F(1,34) = 25.45, p< 0.0001], as well as significant interaction [F(1,34) = 16.24,
p = 0.0003]. Posthoc analysis revealed that only GRwt/wt [t(34) = 6.254, p< 0.0001], but not
GRdim/dim mice [t(34) = 0.737, p = 0.71], showed a significant preference for the paired context
(Fig 7F).
Gene expression analysis in dorsal hippocampus
We compared hippocampal expression of a selection of genes associated with neurogenesis
and synaptic pruning (Bdnf, and its receptor TrkB, and Fmr1), cellular sensitivity to GC stimu-
lation (Fkbp5), and modulation of cognitive processes as well as to the salience network (Drd1,
Drd5). The gene expression levels are shown as relative expression, scaled to average and nor-
malized to housekeeping genes. We compared all expression levels using a 2-way ANOVA on
the log-transformed data with genotype and treatment as factors. Overall, we found that
CORT treatment significantly increased expression levels of Bdnf, Fkbp5 and Drd5, and
decreased expression of TrkB and Drd1 (see Table 2, and Fig 8). For these genes, the contrast
between the genotypes was not significant, and we also found no interaction. Fmr1 compari-
son indicated a significant genotype effect, treatment effect as well as a significant interaction.
Post-hoc contrast analysis (Sidak’s multiple testing corrections) indicated that Fmr1 was sig-
nificantly higher in GRdim/dim at baseline [t(20) = 4.232, p = 0.0025] and that CORT treatment
returned Fmr1 expression back to GRwt/wt levels [t(20) = 3.734, p = 0.0078; GRdim/dim BSL ver-
sus CORT; t(20) = 0.074, p => 0.99, GRwt/wt versus GR dim/dim under CORT].
Glucocorticoids and memory loss
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Discussion
In this study we analysed the behavioural phenotype of female FVB/NJ mice harbouring a
point mutation in the glucocorticoid receptor (GR), known as GRdim/dim, under baseline and
under chronically elevated corticosterone levels. In particular, we compared behaviour span-
ning general activity, emotional behaviour and cognitive performance under these two condi-
tions. In addition, we analysed expression levels of selected genes that have been shown to be
differentially regulated by (i) corticosterone [72–74] and stress [75], (ii) in major depressive
disorders in the hippocampus [29], and (iii) play an important role in cognitive processes espe-
cially in learning impairments reported in preclinical models and clinical population of
depression [76–80]. Tests relying on visual cues were not included since FVB/NJ mice have
been shown to be vision-impaired [81].
Previous behavioural reports on animals with targeted disruption of glucocorticoid receptor
in a C57BL/6J background have demonstrated impaired learning and reference memory in a
short Morris water maze protocol [82, 83], paired with increased explorative behaviour in an
open field and /or in a dark/light box was. In addition, in these GRdim/dim animals (C57BL/6J
background), the circulating corticosterone levels were elevated, both at trough and peak lev-
els, as well after acute stress evoked by forced swimming [83]. In general, C57BL/6J animals
have lower baseline corticosterone levels than FVB/NJ animals (e.g. at baseline 27.5 ng/ml in
comparison to 41.5 ng/ml as reported by [84]), which reflects differences in behavioural
despair anxiety-related exploration in the open field [84]. However, despite increased baseline
levels due to genetic background, GRwt/wt animals in a FVB/NJ background displayed sensitiv-
ity to the protective effects of dexamethasone in a TNF-induced lethal inflammation model
[85], which would indicate that the HPA-axis feedback regulation is not desensitized [85].
Despite the reported cognitive differences in the C57BL/6J background, we observed no geno-
type-specific differences in cognitive nor in emotional behaviour in this GRdim/dim model
(with the exception of a small contrast in open arm visits in the elevated plus maze). Because
we did not observe any difference between GRdim/dim mice and GRwt/wt mice under baseline
conditions, both groups were subjected chronically (4 weeks) to low doses of corticosterone
(36,5 mg/l, CORT) in drinking water. This specific schedule has been shown to robustly induce
anxiety and depression-like behaviour [51, 52, 86], including time spent in the centre of the
Fig 7. Conditioned place preference in GRwt/wt (black symbols) and GRdim/dim mice (white symbols). Animals were
conditioned to locate a food reward in a specific context for 3 days (6 trials). Latency to find the reward (A, C) reduced
over trials, and number of correct trials (B, D) increased over training trials. During training, no effect of genotype was
found under baseline conditions (A, B) and not under CORT treatment (C, D). During testing, both genotype show
clear preference for the correct context under baseline conditions (E), while under CORT treatment, GRdim/dim did not
display a context preference (F). Data are shown as mean ± SEM. � p< 0.05. ��� p< 0.001, ���� P< 0.0001. Baseline:
n = 9 GRwt/wt and n = 7 GRdim/dim mice; CORT: n = 9 GRwt/wt and n = 10 GRdim/dim mice.
https://doi.org/10.1371/journal.pone.0226753.g007
Table 2. Statistical analysis of gene expression levels using 2-Way ANOVA on the log transformed results.
Gene genotype treatment genotype x treatment
DFn, DFd = 1,10
Bdnf F = 2.371, p = 0.139 F = 11.22, p = 0.003 F = 0.191, p = 0.666
TrkB F = 1.832, p = 0.191 F = 100.7, p < 0.0001 F = 3.203, p = 0.0887
Fkbp5 F = 0.010, p = 0.921 F = 88.84, p < 0.0001 F = 0.042, p = 0.839
Fmr1 F = 8.645, p = 0.0081 F = 4.990, p = 0.037 F = 9.269, p = 0.0064
Drd1 F = 0.153, p = 0.699 F = 10.60, p = 0.004 F = 2.278, p = 0.146
Drd5 F = 0.689, p = 0.416 F = 13.27, p = 0.0016 F = 0.210, p = 0.651
https://doi.org/10.1371/journal.pone.0226753.t002
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open field, increased immobility in the forced swim test and suppressed novelty feeding, as
well as impaired learning and memory [51], and reduced cell proliferation in the dendate
gyrus of the adult hippocampus [52, 87]. To investigate the effect of chronic elevated cortico-
sterone levels, we first treated the animals for 4 weeks and repeated behavioural testing while
CORT was maintained at a steady state to avoid acute rebound effects. Corticosterone induced
some genotype unspecific effects, such as hyperactivity in CA, OF, SPSN and EPM, at least in a
subset of animals in both groups, which indicates that CORT effects in FVB/NJ background
might be due to a general reduction in CNS inhibition. Indeed, FVB/NJ mice have been
reported to have increased occurrence of audiogenic seizures and less sensitive to GABAA
ligands [48], both indicative of increased neuronal excitability in the FVB/NJ strain. This
increase in activity was observed in both genotypes especially when placed in a novel environ-
ment, such as the OF, SPSN and in CA. Notably, while GRwt/wt mice show initially high activity
in the overnight cage activity, after a few hours activity reached baseline levels during the
night. Overall, this indicates that this particular strain (FVB/NJ) is more sensitive to low levels
of corticosterone by displaying increases in novelty-induced locomotion.
In contrast to the genotype unspecific changes in activity, we did observe a genotype-spe-
cific effect of CORT on cognitive behaviour in 4 different tests. In particular, we observed
Fig 8. Gene expression level changes in the dorsal hippocampus of genes associated with increases of corticosterone (BDNF, TRKB, Fkbp5, and Fmr1) and stress
and cognition (Drd1, Drd5). Tissue was extracted from animals after behavioral testing (n = 6) and compared to experimental naïve animals as baseline controls
(n = 6). Data are presented as mean +/- SEM as relative expression, normalized to housekeeping genes and scaled to the average across all unknown samples per target, �
p< 0.05; �� p< 0.01; ��� p< 0.0001 (2-way ANOVA and post-hoc comparison with Sidak’s correction for multiple testing).
https://doi.org/10.1371/journal.pone.0226753.g008
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reduced social recognition, reduced spontaneous alternation in the Y-maze, reduced contex-
tual fear memory in a passive avoidance test, and reduced contextual place preference in
GRdim/dim mice under CORT treatment. These cognitive impairments are very likely indepen-
dent of the changes in activity levels, because we observe similar increase in locomotion in
GRwt/wt mice without cognitive impairment. Despite increased activity, GRwt/wt mice show
perfect avoidance by not entering the conditioned context. In tests with higher cognitive load
such as working memory in the Y-maze, number of arm visits were reduced in GRwt/wt mice
under CORT, while the number of alternations were above chance level. Glucocorticoids
(GC), commonly prescribed over extended periods to suppress inflammation and immune
responses, have been reported to cause a variety of behavioural changes, including cognitive
impairment [88]. Furthermore, numerous studies suggest a strong association between ele-
vated GC hormone levels and hippocampal damage [89]. The hippocampus is a major hub for
cognitive processes in the mammalian brain, especially for episodic, spatial and contextual
information, but it is also exceptionally well positioned to detect and respond to stress because
of its rich concentration of GC receptors [90, 91]. Long term exposure to stress or GC results
in numerous changes in the hippocampal structure including neurochemistry, excitability,
neurogenesis, neuronal morphology and even cell death [92].
In our model, we observe an effect of CORT on hippocampus-dependent cognition only in
GRdim/dim mice. There are several possible explanations for this observation. Firstly, we chose
a concentration of CORT that was reported to induce behavioural and cognitive changes in
mice and rats, but is considered a rather low dose [55], reflecting a 3-fold elevation of baseline
corticosterone in C57BL/6J animals. Baseline levels in FVB have been reported to be higher
[84]. Therefore it is possible that the amount we provided in the drinking water had less of an
effect in GRwt/wt mice in this genetic background. In addition, stress sensitivity has been
shown to be different between specific mouse strains [93]. For example, Ibarguen-Vargas et al
reported a differential effect of chronic stress on novelty feeding in C57BL/6 and FVB [93]. In
C57Bl/6, stress increased the reluctance to approach food in a novel environment, but had no
effect on novelty feeding in FVB [93]. Restraining stress induces anxiety-and depression like
behaviour in C57Bl/6, but not in FVB/NJ [94]. Secondly, chronic stress manipulations or
pharmacologically elevating corticosterone levels have been shown to impair cognitive flexibil-
ity (e.g. working memory [95], spatial reference memory [96], and contextual fear learning
(e.g. passive avoidance [97, 98]) in a variety of rodent models, as well as in humans [99–101].
However, depending on the protocols, corticosterone treated animals perform similar to con-
trols [95, 102–105]. So it is possible that in other cognitive protocols, e.g. in the hidden plat-
form version of the Morris water maze, GRwt/wt mice might have performed worse under
chronic corticosterone. However, we chose not to perform cognitive tests that rely mostly on
visual acuity with this strain, since FVB have been reported to develop retinal degeneration
[106].
Oitzl et al reported impaired spatial memory for GRdim/dim mice in the Morris water maze
under basal conditions [83]. They argued that the observed cognitive deficit was based on the
lack of DNA binding-dependent transcriptional regulation by GR, and not to the elevated lev-
els of corticosterone at baseline and under stress [83]. Indeed, it is worth noting that exposure
to water triggered a higher and much longer release of corticosterone in the GRdim/dim mice.
We did not observe cognitive deficits in GRdim/dim mice under baseline conditions in the CPP,
PA or Y-maze. This discrepancy could be in the test protocol that poses a different demand on
cognitive function. Spatial learning in the Morris water maze, as well as place preference, pas-
sive avoidance, and spontaneous alternation all rely on hippocampal processes, but they differ
in their cognitive load [107]. So it is possible that our protocols were easier to learn and there-
fore no genotype effect was evident. In addition, we performed an extensive behavioural
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battery, employing a variety of behavioural protocols in a well-defined order. However, test
order, as well as test history has been shown to affect mouse behaviour and even mask cogni-
tive deficits [108, 109].
The molecular picture of GC action in the brain is far from complete. However, it is clear
that GCs exert direct transcriptional effects on many different components of the neurotrans-
mission cascade. These components include patterns of gene expression underlying signal
transduction, neuronal structure, vesicle recycling, neurotransmitter catabolism, motor activ-
ity, cell adhesion, neuronal outgrowth and survival and energy metabolism [110]. Because, in
general, GRdim/dim phenotypes are associated with a lack in transcriptional control of GR
dimers, and because the observed phenotypes are hippocampus controlled, we investigated
gene expression of different key genes in the dorsal hippocampus. We focussed on genes that
have been shown to be important in cognitive processes and are associated with stress and
MDD, such as Bdnf and its receptor TrkB, D1-like receptors (Drd1 and Drd5) and Fmr1. In
addition, we also included Fkbp5, which regulates GR sensitivity to GC, and overexpression of
Fkbp5 has been associated with increased risk of anxiety and MDD in patients [111]. We
found that CORT increased expression levels of Bdnf, Fkbp5 and Drd5, while Drd1 and TrkB
were downregulated. Both the upregulation of Fkbp5 and downregulation of TrkB would be
expected as a consequence of chronic GC levels. Upregulation of Fkbp5 is induced by increases
in GC levels via intronic hormone response elements acting as a short negative feed-back loop
[111]. Similarly, down regulation of BDNF/TrkB pathway is a hallmark of stress-induced
changes in mouse and in MDD [112]. Changes in Fkbp5 and Bdnf/TrkB expression support
the behavioural observations under chronic CORT administration. Interestingly, it seems the
CORT administration affected the expression of Drd1 and Drd5 differentially. Both receptors
are located in the hippocampus and have been attributed to learning and memory processes.
However, due to lack of subtype specific ligands, there is only limited information regarding
the subtype specific influences on cognitive processes. Furthermore, Drd1 is much more abun-
dant than Drd5, which made interpretation of behavioural phenotype of for example Drd5 spe-
cific knockout difficult. However, there is growing evidence, that Drd5 as well as Drd1 are
involved in cognitive processes by either modulating NMDA receptors or by releasing acetyl-
choline [113–115]. We observed a difference in CORT regulation of the Fmr1 gene expression
between GRwt/wt and GRdim/dim mice. The data suggest that the phenotypic problem in con-
taining a good memory after chronic stress in GRdim/dim mice is not reflected in the lack of
induction of repression of these genes in the hippocampus, and it may be that other genes, not
tested here or as yet not recognized, are regulated by GR dimers in this specific control.
Supporting information
S1 Fig. Open field. Two examples of increased rotational behaviour after CORT treatment.
The two panels on the left show respective tracks for the first 20s of the open field experiment
in two mice (A and B) under baseline conditions. Under CORT, the behaviour changes dra-
matically to fast running in circles in the same mice.
(TIF)
S2 Fig. Elevated plus maze. GRdim/dim mice crossed into open arms significantly more, rela-
tive to the closed arm, when compared to controls (B). In conjunction with similar general
activity [total crosses) (A), indicates that GRdim/dim mice are less anxious than WT controls.
Data are presented as mean +/- SEM. � denotes p< 0.05 between genotypes.
(TIF)
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